The main reason for this difference lies in the disparity between preclinical research and clinical research, that is, the contradiction that GLP-1 receptor agonists show muscle-protective effects in animal models but are accompanied by fat-free body weight loss in humans
National Consensus on Semaglutide in Cardiology: From Clinical Evidence to Clinical Translation
Early receptor and endocrine findings, limited human pharmacology studies, and one proof-of-concept clinical program do not establish an approved indication, general safety, or effectiveness
The proportion of Americans who know someone using weight loss drugs has risen from 12% this time last year and from 4% in February 2023
Semaglutide doesnt directly cause skin sagging, but the weight loss associated with it does
furthermore, these data are likely gross underestimates of the true global impact of the virus